Market Overview - The Shanghai Composite Index closed at 3875.53 points, with a change of 0.46% [1] - The total trading volume of A-shares reached 27,776.47 billion yuan [1] Technical Analysis - A total of 63 A-shares experienced a "death cross" where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Haitai Biological: 5-day MA at 50.56 yuan, 10-day MA at 51.97 yuan, a difference of -2.72% [1] - Titan Technology: 5-day MA at 27.25 yuan, 10-day MA at 27.85 yuan, a difference of -2.16% [1] - Anglikang: 5-day MA at 50.17 yuan, 10-day MA at 51.27 yuan, a difference of -2.15% [1] Individual Stock Performance - Haitai Biological: Today's change of -2.67%, with a turnover rate of 8.82% [1] - Titan Technology: Today's change of -2.29%, with a turnover rate of 4.22% [1] - Anglikang: Today's change of -0.85%, with a turnover rate of 6.98% [1] - Other stocks with notable performance include: - Rainbow Group: Today's change of -0.13%, with a turnover rate of 3.47% [1] - Wanli Stone: Today's change of -0.51%, with a turnover rate of 2.18% [1] Additional Observations - The market shows a trend of declining stock prices for several companies, indicating potential bearish sentiment [1][2] - The analysis of moving averages suggests a cautious approach for investors focusing on these stocks [1][2]

Market Overview - The Shanghai Composite Index is at 3864.71 points with a change of 0.18% [1] - The total trading volume of A-shares is 138.21 billion yuan [1] Technical Analysis - 62 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Haitai Biological: 5-day MA is -2.28% below the 10-day MA [1] - Titan Technology: 5-day MA is -2.07% below the 10-day MA [1] - Anglikang: 5-day MA is -1.88% below the 10-day MA [1] Individual Stock Performance - Haitai Biological (300683): Today's change is +1.95%, with a 5-day MA of 51.01 yuan and a 10-day MA of 52.20 yuan [1] - Titan Technology (688133): Today's change is -1.41%, with a 5-day MA of 27.30 yuan and a 10-day MA of 27.88 yuan [1] - Anglikang (002940): Today's change is +1.84%, with a 5-day MA of 50.44 yuan and a 10-day MA of 51.40 yuan [1] - Other stocks with notable performance include: - Rainbow Group (300314): +0.04% change, 5-day MA of 23.44 yuan [1] - Wanli Stone (002785): -0.89% change, 5-day MA of 29.62 yuan [1] Summary of Stocks with Death Cross - A list of stocks experiencing a death cross includes: - Haitai Biological, Titan Technology, Anglikang, and others with varying degrees of percentage differences between their moving averages [1][2]

Summary of Key Points Core Viewpoint - The company plans to continue using part of the idle raised funds for cash management, ensuring that it does not affect the investment projects and the safety of the raised funds, while aiming to increase returns for the company and its shareholders [1][4][6]. Fundraising Basic Situation - The company raised a total of RMB 1,003,512,562.56 from the issuance of 7,624,896 A shares at a price of RMB 131.61 per share, with a net amount of RMB 985,184,001.46 after deducting related issuance costs [1]. Previous Use of Idle Funds - The company approved the use of up to RMB 400 million of idle funds for cash management, focusing on high-security and liquid investment products, with a rolling usage period of 12 months [2][3]. Current Cash Management Plan - The company intends to use up to RMB 400 million of idle funds for cash management, with a focus on safe and liquid investment products, maintaining the same 12-month usage period [3][4]. Investment Purpose - The goal is to improve the efficiency of fund usage and increase returns for the company and shareholders without affecting the investment projects [3][4]. Investment Products - The company will invest in high-security and liquid products such as agreement deposits, structured deposits, time deposits, notice deposits, and large certificates of deposit, ensuring these funds are not used for pledging or securities investment [3][4][7]. Decision Validity Period - The decision is valid for 12 months from the date of board approval [3][4]. Authorization Matters - The board authorizes the management to make investment decisions and sign relevant documents within the approved limits and validity period [4][6]. Information Disclosure - The company will comply with relevant regulations for timely information disclosure and will not change the purpose of the raised funds [4][8]. Cash Management Income Distribution - Income from cash management will be used to supplement investment project funding and daily operational liquidity, with funds returned to the special account upon maturity [4][6]. Impact on the Company - The cash management plan will not affect the normal operation of the company or the investment projects, and it aims to generate additional returns for the company and shareholders [4][6][7]. Independent Director and Supervisory Board Opinions - Both the independent directors and the supervisory board agree that the cash management plan is compliant with regulations and beneficial for the company and shareholders, ensuring no harm to the interests of minority shareholders [6][7][8].

Group 1 - The core viewpoint of the announcement is that the Supervisory Board of Titan Technology has approved the 2025 semi-annual report and confirmed its compliance with relevant laws and regulations [1][2][3] - The meeting of the Supervisory Board was held on August 27, 2025, with all three supervisors present, ensuring the legality and validity of the resolutions made [1] - The Supervisory Board unanimously agreed that the semi-annual report accurately reflects the company's financial status and operational results for the first half of 2025 [2][3] Group 2 - The Supervisory Board confirmed that the management of raised funds complies with the relevant regulations and that there are no violations in the use of these funds [2][3] - The company plans to continue using up to RMB 400 million of idle funds from the 2021 A-share issuance for cash management in safe and liquid investment products, ensuring that this does not affect the ongoing investment projects [3][4] - The resolution regarding the use of idle funds was also unanimously approved by the Supervisory Board [4][5]

Core Viewpoint - Shanghai Titan Technology Co., Ltd. is convening its first extraordinary general meeting of shareholders in 2025 to discuss the proposal for the registration and issuance of short-term financing bonds, aimed at optimizing its debt structure and reducing financial costs [5][10]. Meeting Procedures - The meeting will take place on September 5, 2025, at 14:30, in Shanghai, with both on-site and online voting options available [6]. - Shareholders or their representatives must arrive 30 minutes prior to the meeting for registration and must present necessary identification documents [2]. - The meeting will follow a structured agenda, including the announcement of attendees, discussion of proposals, and voting on resolutions [7]. Proposal for Short-term Financing Bonds - The company plans to apply for the registration of short-term financing bonds not exceeding RMB 100 million, with a registration validity of two years [8]. - The funds raised will be used for repaying interest-bearing debts, project construction, and supplementing working capital [8]. - The board of directors seeks authorization from the shareholders to manage the issuance process, including determining the timing, scale, and use of funds [9]. Impact and Approval Process - The issuance of these bonds is expected to enhance the company's financial flexibility and support its operational needs without significantly impacting its normal business operations [10]. - The proposal has already been approved by the company's board and supervisory board and requires shareholder approval and registration with the China Interbank Market Dealers Association to proceed [10].

Core Viewpoint - Titan Technology (688133.SH) reported a decline in revenue and net profit for the first half of 2025, indicating challenges in its operational performance compared to peers in the industry [1][3]. Financial Performance - The company's total revenue for the first half of 2025 was 1.219 billion yuan, a decrease of 177 million yuan or 12.70% year-on-year [1]. - The net profit attributable to shareholders was 9.7652 million yuan, ranking 126th among disclosed peers [1]. - The net cash inflow from operating activities was -84.007 million yuan, ranking 161st among disclosed peers, a decrease of 9.3102 million yuan compared to the same period last year [1]. Financial Ratios - The latest debt-to-asset ratio stood at 40.76%, ranking 105th among disclosed peers, remaining stable compared to the previous quarter but increasing by 0.88 percentage points year-on-year [3]. - The gross profit margin was 22.29%, a decrease of 0.96 percentage points from the previous quarter [4]. - The return on equity (ROE) was 0.35%, ranking 135th among disclosed peers [4]. - The diluted earnings per share were 0.06 yuan, ranking 115th among disclosed peers [4]. - The total asset turnover ratio was 0.25 times, a decrease of 0.06 times or 17.99% year-on-year [4]. - The inventory turnover ratio was 0.88 times, ranking 154th among disclosed peers, a decrease of 0.20 times or 18.47% year-on-year [4]. Shareholder Structure - The number of shareholders was 7,718, with the top ten shareholders holding a total of 64.4956 million shares, accounting for 39.22% of the total share capital [4]. - The top shareholders include: - Xie Yingbo: 9.88% - Zhang Qing: 4.55% - Dehru: 4.55% - Wang Jingyu: 4.58% - Xu Fengyuan: 4.58% - Shanghai Gao Yi Asset Management Partnership: 3.04% - Suzhou Zhongding No. 5 Equity Investment Fund: 2.82% - Chen Pinwang: 1.89% - CITIC Securities Co., Ltd.: 1.67% - Basic Pension Insurance Fund: 1.60% [4].

Core Viewpoint - Shanghai Titan Technology Co., Ltd. plans to continue using part of its idle raised funds for cash management, with a maximum amount of 400 million yuan, ensuring that it does not affect the construction and use of the raised funds investment projects [1][4]. Fundraising Situation - In 2022, Titan Technology issued 7,624,896 shares at a price of 131.61 yuan per share, raising a total of approximately 1.003 billion yuan, with a net amount of about 985 million yuan after deducting related issuance costs [2]. Previous Cash Management Situation - In August 2024, the company approved the use of up to 400 million yuan of idle raised funds for cash management, with funds stored in a special account for raised funds, allowing for immediate withdrawal [3]. Impact on the Company - The continued use of idle raised funds for cash management will not affect the normal operation of the investment projects and aims to generate more returns for the company and its shareholders [4]. Decision-Making Process and Opinions - The cash management matter has been approved by the board of directors and the supervisory board, and does not require submission to the shareholders' meeting. Independent directors and the supervisory board have expressed agreement, stating that the matter is legal and compliant, and aligns with the interests of the company and shareholders [5].

中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为上海泰坦科技 股份有限公司（以下简称"泰坦科技"或"公司"） 2021 年度向特定对象发行股票的 保荐人，根据《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规则 （2025 年 4 月修订）》《上海证券交易所科创板上市公司自律监管指引第 1 号——规 范运作》《科创板上市公司持续监管办法（试行）》等有关法律法规和规范性文件的要 求，对泰坦科技使用部分闲置募集资金进行现金管理的事项进行了审慎核查，并出具本 核查意见。核查情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海泰坦科技股份有限公司向特定对象发 行股票注册的批复》（证监许可〔2022〕871 号），上海泰坦科技股份有限公司向特定 对象发行 A 股股票 7,624,896 股，发行价格为人民币 131.61 元/股，本次发行的募集资金 总额为人民币 1,003,512,562.56 元，扣除相关发行费用人民币 18,328,561.10 元，募集资 金净额为人民币 985,184,001.46 元，上述资金已全部到位，经大信会计师事务所（特殊 普通合伙）审验并于 ...

Core Viewpoint - Titan Technology (688133) reported a decline in revenue for the first half of 2025, primarily due to strategic adjustments in its operations aimed at aligning customer demand with company capabilities [1] Financial Performance - The company achieved an operating revenue of 1.219 billion yuan, representing a year-on-year decrease of 12.7% [1] - The net profit attributable to shareholders was 9.7652 million yuan, showing a significant year-on-year increase of 91.55% [1] - Basic earnings per share were reported at 0.06 yuan [1] Strategic Adjustments - The decline in operating revenue was attributed to the company's decision to proactively abandon certain unprofitable businesses or those with long capital cycles, in order to better match customer demand with its operational capabilities [1]

上海泰坦科技股份有限公司 关于公司 2025 年度"提质增效重回报"专项行动方案的 半年度评估报告 本评估报告系基于公司实际经营情况制定，所涉及的经营目标、发展战 略等前瞻性陈述不构成公司对投资者的实质承诺，提请投资者注意相关风 险。 上海泰坦科技股份有限公司（以下简称"公司"）积极响应并践行"以投资 者为本"的发展理念，推动公司持续优化经营、规范治理和积极回报投资者， 大力提高公司质量，助力信心提振、资本市场稳定和经济高质量发展，基于对 公司发展前景的信心和对公司长期投资价值的认可，公司在 2025 年初制定了 《2025 年度"提质增效重回报"行动方案》。2025 年上半年，本行动方案主要 举措的进展及成效情况如下： 一、聚焦主业，推进年度重点工作，持续提升核心竞争力 一直以来，公司专注于为科研工作者和质量控制人员提供一站式实验室产 品与配套全方位的综合服务，以构建科研配套服务行业购物平台为基础，通过 建立全国性营销服务网络和整合丰富完善的产品物料供应体系，满足实验室客 户的各类需求。 公司在 2024 年初提到，未来三年，公司将围绕以下三方面的核心战略，聚 焦主业，继续提升公司核心竞争力，在核心竞争力的 ...